Literature DB >> 3876384

Base specificity and idiotypy of anti-DNA autoantibodies reactive with synthetic nucleic acids.

D W Ballard, E W Voss.   

Abstract

Synthetic nucleic acid reactivities and the distribution of idiotypes associated with poly(dA) and poly(dT) specificities were evaluated among both monoclonal and polyclonal anti-DNA antibodies from autoimmune New Zealand mice. Ten monoclonal anti-DNA antibodies (IgG2a or IgG2b), derived from NZB/NZW mice and reactive with natural DNA (duplex and/or heat-denatured), were found to collectively exhibit a diverse binding pattern with six deoxyribohomopolymers. Several monoclonal antibodies displayed reactivity with poly(dT) comparable to that with natural DNA. Serologic studies indicated that polyclonal anti-DNA autoantibodies from NZW/NZW mice and both parental strains also cross-reacted with various homopolymers and bound preferentially with those containing pyrimidines, particularly poly(dT), relative to purines. Detailed binding analyses with two poly(dT)-reactive monoclonal antibodies demonstrated that stable DNA/anti-DNA complexes were formed with synthetic oligomers containing six to 10 nucleotides; binding to such antigens was relatively insensitive to ionic strength and inversely dependent on temperature. Both antibodies exhibited preferential binding (greater than or equal to 10-fold) with poly(dT) relative to poly(dU), suggesting the importance of the C5-methyl group and/or helical conformation in pyrimidine base recognition. Idiotypes on poly(dA)-specific and poly(dT)-specific monoclonal antibodies were found to be reciprocally distinct, localized at or near active site residues, and expressed at low levels (less than 10 to 130 ng/ml) in anti-DNA sera from all three New Zealand strains. These findings suggest that: nucleotide base determinants are significantly involved in DNA/anti-DNA interactions; poly(dT) represents a major cross-reactive synthetic antigen; and idiotype expression among lupus autoantibodies which recognize such determinants may be diverse.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876384

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Production and characterization of anti-DNA-RNA monoclonal antibodies and their application in Listeria detection.

Authors:  I Fliss; M St Laurent; E Emond; R Lemieux; R E Simard; A Ettriki; S Pandian
Journal:  Appl Environ Microbiol       Date:  1993-08       Impact factor: 4.792

2.  Antigen structural requirements for recognition by a cyclobutane thymine dimer-specific monoclonal antibody.

Authors:  Y Komatsu; T Tsujino; T Suzuki; O Nikaido; E Ohtsuka
Journal:  Nucleic Acids Res       Date:  1997-10-01       Impact factor: 16.971

3.  Identification of a lipid peroxidation product as the source of oxidation-specific epitopes recognized by anti-DNA autoantibodies.

Authors:  Natsuki Otaki; Miho Chikazawa; Ritsuko Nagae; Yuki Shimozu; Takahiro Shibata; Sohei Ito; Yoshinari Takasaki; Junichi Fujii; Koji Uchida
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

4.  A ribosomal DNA fragment of Listeria monocytogenes and its use as a genus-specific probe in an aqueous-phase hybridization assay.

Authors:  E Emond; I Fliss; S Pandian
Journal:  Appl Environ Microbiol       Date:  1993-08       Impact factor: 4.792

5.  Ligand recognition by murine anti-DNA autoantibodies. II. Genetic analysis and pathogenicity.

Authors:  P C Swanson; R L Yung; N B Blatt; M A Eagan; J M Norris; B C Richardson; K J Johnson; G D Glick
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

6.  Variations in duplex DNA conformation detected by the binding of monoclonal autoimmune antibodies.

Authors:  R P Braun; J S Lee
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

7.  A single germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus.

Authors:  Y Naparstek; J André-Schwartz; T Manser; L J Wysocki; L Breitman; B D Stollar; M Gefter; R S Schwartz
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.